Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Atossa Genetics Initiates Additional Drug Development Program
Atossa Genetics to Present at 6th Annual LD Micro Invitational Conference on June 7th, 2016
Atossa Genetics Announces $10 Million At-the-Market Common Stock Purchase Agreement with Aspire Capital Fund, LLC
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!